Blu – Pagina 70 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Giugno 17, 2024 Alice Lione

Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial

Kim NH, Moon JS, Lee YH, et al.
Diabetes Obes Metab. Pub. online 11 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective

Del Prato S, Giorgino F, Szafranski K, Poon Y
Diabetes Obes Metab. Pub. online 10 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

How do lifestyle factors modify the association between genetic predisposition and obesity-related phenotypes? A 4-way decomposition analysis using UK Biobank

Zhang M, Ward J, Strawbridge RJ, et al.
BMC Med. Pub. online 10 Jun 2024.

Leggi

Giugno 17, 2024 Alice Lione

Key results from observational studies and real-world evidence of sodium-glucose cotransporter-2 inhibitor effectiveness and safety in reducing cardio-renal risk

Nyström T
Diabetes Obes Metab. Pub. online 10 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

A phase 2 randomized trial of survodutide in MASH and fibrosis

Sanyal AJ, Bedossa P, Fraessdorf M, et al.
N Engl J Med. Pub. online 7 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Partial clinical remission of type 1 diabetes in Swedish children – a longitudinal study from the Swedish National Quality Register (SWEDIABKIDS) and the Better Diabetes Diagnosis (BDD) study

Fureman AL, Bladh M, Carlsson A, et al.
Diabetes Technol Ther. Pub. online 6 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): study protocol of a phase 2 double-blinded randomised placebo-controlled trial

Frampton R, Snaith JR, Hocking S, et al.
Diabet Med. Pub. online 9 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals

Mizani MA, Dashtban A, Pasea L, et al.
BMJ Open Diabetes Res Care. Pub. online 4 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity

Winther JB, Holst JJ
Diabetes Obes Metab. Pub. online 9 Jun 2024.

Leggi

Giugno 13, 2024 Alice Lione

Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: proof-of-concept results from the DECIDE-CV clinical programme

Marques P, Mavrakanas TA, Guida J, et al.
Diabetes Obes Metab. Pub. online 3 Jun 2024.

Leggi